Sarepta Therapeutics (SRPT) Profit After Tax Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 173.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173.96% |
| Dec 31, 2025 | -359.18% |
| Sep 30, 2025 | -250.45% |
| Jun 30, 2025 | 2,947.86% |
| Mar 31, 2025 | -1,338.98% |
| Dec 31, 2024 | 248.37% |
| Sep 30, 2024 | 182.10% |
| Jun 30, 2024 | 126.98% |
| Mar 31, 2024 | 106.99% |
| Dec 31, 2023 | 141.79% |
| Sep 30, 2023 | 84.12% |
| Jun 30, 2023 | 89.66% |
| Mar 31, 2023 | -392.03% |
| Dec 31, 2022 | 10.44% |
| Sep 30, 2022 | -435.35% |
| Jun 30, 2022 | -184.36% |
| Mar 31, 2022 | 37.20% |
| Dec 31, 2021 | 35.57% |
| Sep 30, 2021 | 75.50% |
| Jun 30, 2021 | 46.03% |
| Mar 31, 2021 | -856.15% |
| Dec 31, 2020 | 19.68% |
| Sep 30, 2020 | -55.55% |
| Jun 30, 2020 | 45.43% |
| Mar 31, 2020 | 77.18% |
| Dec 31, 2019 | -67.29% |
| Sep 30, 2019 | -65.36% |
| Jun 30, 2019 | -152.96% |
| Mar 31, 2019 | -116.73% |
| Dec 31, 2018 | -487.11% |
| Sep 30, 2018 | -60.04% |
| Jun 30, 2018 | -73.31% |
| Mar 31, 2018 | -142.05% |
| Dec 31, 2017 | 72.87% |
| Sep 30, 2017 | 15.88% |
| Jun 30, 2017 | -1.20% |
| Mar 31, 2017 | 240.69% |
| Dec 31, 2016 | -36.75% |
| Sep 30, 2016 | -9.25% |
| Jun 30, 2016 | -48.86% |
| Mar 31, 2016 | 2.91% |
| Dec 31, 2015 | -45.63% |
| Sep 30, 2015 | -77.72% |
| Jun 30, 2015 | -23.55% |
| Mar 31, 2015 | -117.73% |
| Dec 31, 2014 | -403.58% |
| Sep 30, 2014 | 30.46% |
| Jun 30, 2014 | -77.81% |
| Mar 31, 2014 | 32.82% |
| Dec 31, 2013 | 85.79% |
| Sep 30, 2013 | 15.18% |
| Jun 30, 2013 | -337.01% |
| Mar 31, 2013 | -137.71% |
| Dec 31, 2012 | -4,301.91% |
| Sep 30, 2012 | -1,132.69% |
| Jun 30, 2012 | 528.46% |
| Mar 31, 2012 | -1,065.85% |
| Dec 31, 2011 | 14.60% |
| Sep 30, 2011 | -8.21% |
| Jun 30, 2011 | 116.79% |